Landec Corporation
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. Its prod… Read more
Landec Corporation (LDE) - Total Assets
Latest total assets as of August 2025: €235.20 Million EUR
Based on the latest financial reports, Landec Corporation (LDE) holds total assets worth €235.20 Million EUR as of August 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Landec Corporation - Total Assets Trend (2014–2025)
This chart illustrates how Landec Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Landec Corporation - Asset Composition Analysis
Current Asset Composition (May 2025)
Landec Corporation's total assets of €235.20 Million consist of 35.8% current assets and 64.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.5% |
| Accounts Receivable | €28.69 Million | 12.0% |
| Inventory | €32.29 Million | 13.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €4.20 Million | 1.8% |
| Goodwill | €13.88 Million | 5.8% |
Asset Composition Trend (2014–2025)
This chart illustrates how Landec Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Landec Corporation's current assets represent 35.8% of total assets in 2025, an increase from 29.0% in 2014.
- Cash Position: Cash and equivalents constituted 3.5% of total assets in 2025, down from 4.5% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 33.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 13.5% of total assets.
Landec Corporation Competitors by Total Assets
Key competitors of Landec Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Landec Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Landec Corporation generates 0.54x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Landec Corporation is currently not profitable relative to its asset base.
Landec Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.80 | 1.83 | 0.89 |
| Quick Ratio | 1.67 | 0.80 | 0.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €53.97 Million | € 33.66 Million | € -19.73 Million |
Landec Corporation - Advanced Valuation Insights
This section examines the relationship between Landec Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 203.86 |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | -5.8% |
| Total Assets | €239.34 Million |
| Market Capitalization | $75.13 Million USD |
Valuation Analysis
Below Book Valuation: The market values Landec Corporation's assets below their book value (0.31 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Landec Corporation's assets decreased by 5.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Landec Corporation (2014–2025)
The table below shows the annual total assets of Landec Corporation from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-05-31 | €239.34 Million | -5.76% |
| 2024-05-31 | €253.96 Million | -0.47% |
| 2023-05-31 | €255.15 Million | -13.64% |
| 2022-05-31 | €295.44 Million | -41.26% |
| 2021-05-31 | €502.92 Million | -7.09% |
| 2020-05-31 | €541.31 Million | +4.28% |
| 2019-05-31 | €519.09 Million | +28.26% |
| 2018-05-31 | €404.70 Million | +12.85% |
| 2017-05-31 | €358.61 Million | +4.41% |
| 2016-05-31 | €343.47 Million | -0.86% |
| 2015-05-31 | €346.46 Million | +10.47% |
| 2014-05-31 | €313.62 Million | -- |